You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0172 Economic outcomes, treatment patterns, and adverse events and reactions for patients prescribed infliximab or ct-p13 in the turkish population

Article info

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0172 Economic outcomes, treatment patterns, and adverse events and reactions for patients prescribed infliximab or ct-p13 in the turkish population
Free

Authors

Citation

Phillips K, Juday T, Zhang Q, et al
SAT0172 Economic outcomes, treatment patterns, and adverse events and reactions for patients prescribed infliximab or ct-p13 in the turkish population
Annals of the Rheumatic Diseases 2017;76:835.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions